Application of high-quality nursing combined with drug therapy in lower respiratory tract infections and its effect on changes of serum IL-2 and TNF in patients High-quality nursing combined with drug therapy in lower respiratory tract infections

Main Article Content

Xuejun Zhang
Xiaoyan Yu

Keywords

Quality care; medication; lower respiratory infections

Abstract

In this study patients in the observation group were given high-quality care in combination with sparfloxacin and amikacin. The cough disappearance time, moist rales disappearance time, and fever symptom disappearance time were significantly shorter in the observation group than in the control group, and the differences were statistically significant. The application of high-quality nursing combined with drug therapy in lower respiratory tract infections can effectively alleviate clinical symptoms, shorten the length of hospital stay, improve the quality of life of patients, and help regulate the levels of serum IL-2 and TNF, and promote early recovery of patients.

Downloads

Download data is not yet available.
Abstract 5 | PDF Downloads 0

References

[1]Hansen Line Sloth,Lykkegaard Jesper,Thomsen Janus Laust. Acute lower respiratory tract infections: Symptoms, findings and management in Danish general practice.[J]. The European journal of general practice,2020,26(1).
[2]Paula Haataja,Päivi Korhonen,Riitta Ojala. Hospital admissions for lower respiratory tract infections after early‐, late‐, and post‐term birth[J]. Paediatric and Perinatal Epidemiology,2020,34(2).
[3]. Respiratory Tract Infections; November/December 2016 Annals of Family Medicine tip sheet[J]. NewsRx Health & Science,2016.
[4]Shu-Chen Kuo,Chun-Eng Liu,Po-Liang Lu. Activity of ceftolozane-tazobactam against Gram-negative pathogens isolated from lower respiratory tract infections in the Asia-Pacific region: SMART 2015-2016[J]. International Journal of Antimicrobial Agents,2020,55(3).
[5]L.M. Vos,J.J. Oosterheert. Testing for viral infections in severe lower respiratory tract infections; the unpredictable effects of diagnostic certainty[J]. Clinical Microbiology and Infection,2019,25(11).
[6]Gu Liming,Deng Huixiong,Ren Zhihui. Dynamic Changes in the Microbiome and Mucosal Immune Microenvironment of the Lower Respiratory Tract by Influenza Virus Infection.[J]. Frontiers in microbiology,2019,10.
[7]Liu Yang,Zhang Yan,Zhao Wanyu. Pharmacotherapy of Lower Respiratory Tract Infections in Elderly-Focused on Antibiotics.[J]. Frontiers in pharmacology,2019,10.
[8]Tchatchouang Serges,Nzouankeu Ariane,Kenmoe Sebastien. Bacterial Aetiologies of Lower Respiratory Tract Infections among Adults in Yaoundé, Cameroon.[J]. BioMed research international,2019,2019.
[9]Teepe Jolien,Broekhuizen Berna Dl,Goossens Herman. Clinical relevance of bacterial resistance in lower respiratory tract infection in primary care: secondary analysis of a multicentre European trial.[J]. The British journal of general practice : the journal of the Royal College of General Practitioners,2018,68(674).
[10]Varsha Gajbhiye,Ranjana Kale,Krishnarao Vilhekar. Drug utilization study on antimicrobials use in lower respiratory tract infection in Pediatric Intensive Care Unit of Rural Tertiary Care Hospital[J]. Journal of Medical Society,2016,30(3).
[11]Trang D. Trinh,Evan J. Zasowski,Kimberly C. Claeys. Multidrug-resistant Pseudomonas aeruginosa lower respiratory tract infections in the intensive care unit: Prevalence and risk factors[J]. Diagnostic Microbiology & Infectious Disease,2017,89(1).
[12]Mewes Janne C,Pulia Michael S,Mansour Michael K. The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised patients with suspected sepsis or lower respiratory tract infections in the US: A health economic model analysis.[J]. PloS one,2019,14(4).
[13]Lee Sze Hwei,Ruan Sheng-Yuan,Pan Sung-Ching. Performance of a multiplex PCR pneumonia panel for the identification of respiratory pathogens and the main determinants of resistance from the lower respiratory tract specimens of adult patients in intensive care units.[J]. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi,2019,52(6).
[14]L.M. Vos,J.J. Oosterheert. Testing for viral infections in severe lower respiratory tract infections; the unpredictable effects of diagnostic certainty[J]. Clinical Microbiology and Infection,2019,25(11).
[15]José M. Molero,Ana Moragas,Beatriz González López‐Valcárcel. Reducing antibiotic prescribing for lower respiratory tract infections 6 years after a multifaceted intervention[J]. International Journal of Clinical Practice,2019,73(5).
[16]Chikara Ogimi,Elizabeth M. Krantz,Jonathan L. Golob. Antibiotic Exposure Prior to Respiratory Viral Infection Is Associated with Progression to Lower Respiratory Tract Disease in Allogeneic Hematopoietic Cell Transplant Recipients[J]. Biology of Blood and Marrow Transplantation,2018,24(11).
[17]Feldman Charles,Richards Guy. Appropriate antibiotic management of bacterial lower respiratory tract infections.[J]. F1000Research,2018,7.
[18]Raban Magdalena Z,Gasparini Claudia,Li Ling. Effectiveness of interventions targeting antibiotic use in long-term aged care facilities: a systematic review and meta-analysis.[J]. BMJ open,2020,10(1).
[19]Gai Xiao-Yan,Bo Shi-Ning,Shen Ning. Pharmacokinetic-pharmacodynamic analysis of ciprofloxacin in elderly Chinese patients with lower respiratory tract infections caused by Gram-negative bacteria.[J]. Chinese medical journal,2019,132(6).
[20]Bandar Alosaimi,Maaweya E. Hamed,Asif Naeem. MERS-CoV infection is associated with downregulation of genes encoding Th1 and Th2 cytokines/chemokines and elevated inflammatory innate immune response in the lower respiratory tract[J]. Cytokine,2020,126.

DB Error: Unknown column 'Array' in 'where clause'